OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.990
-0.050 (-2.45%)
At close: Oct 10, 2025, 4:00 PM EDT
1.900
-0.090 (-4.52%)
After-hours: Oct 10, 2025, 5:12 PM EDT

OS Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-14.28-8.88-7.79-6.25-7.42
Depreciation & Amortization
-1.432.651.152.07
Stock-Based Compensation
-0.29---
Other Adjustments
-0.010.120.360.37
Changes in Accounts Payable
0.03-1.051.350.220.86
Changes in Accrued Expenses
0.080.920.670.73-0.28
Operating Cash Flow
-11.56-7.28-3.01-3.79-4.4
Capital Expenditures
-----0.01
Other Investing Activities
--00.230.21
Investing Cash Flow
--00.230.2
Short-Term Debt Issued
-0.25---
Short-Term Debt Repaid
--0.25---
Long-Term Debt Issued
---3.822.95
Net Long-Term Debt Issued (Repaid)
---3.822.95
Issuance of Common Stock
-6.733.16--
Net Common Stock Issued (Repurchased)
-6.733.16--
Issuance of Preferred Stock
-6.05---
Net Preferred Stock Issued (Repurchased)
-6.05---
Other Financing Activities
---0.28-0.170.1
Financing Cash Flow
14.7412.782.873.653.05
Net Cash Flow
2.715.49-0.130.09-1.15
Beginning Cash & Cash Equivalents
0.090.040.170.081.23
Ending Cash & Cash Equivalents
2.85.530.040.170.08
Free Cash Flow
-11.56-7.28-3.01-3.79-4.41
Free Cash Flow Per Share
-0.55-0.59-0.55-0.76-0.88
Levered Free Cash Flow
-16.14-9.59-3.25-0.46-1.93
Unlevered Free Cash Flow
-15.13-5.520.33-2.35-2.2
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q